[논문]Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)

Calixto, J.B.

doi:10.1590/S0100-879X2000000200004

Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents) 원문보기

Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas, v.33 no.2, 2000년, pp.179 - 189

Calixto, J.B. (Universidade Federal de Santa Catarina, Brasil)

Abstract ▼ AI-Helper

This review highlights the current advances in knowledge about the safety, efficacy, quality control, marketing and regulatory aspects of botanical medicines. Phytotherapeutic agents are standardized herbal preparations consisting of complex mixtures of one or more plants which contain as active ingredients plant parts or plant material in the crude or processed state. A marked growth in the worldwide phytotherapeutic market has occurred over the last 15 years. For the European and USA markets alone, this will reach about $7 billion and $5 billion per annum, respectively, in 1999, and has thus attracted the interest of most large pharmaceutical companies. Insufficient data exist for most plants to guarantee their quality, efficacy and safety. The idea that herbal drugs are safe and free from side effects is false. Plants contain hundreds of constituents and some of them are very toxic, such as the most cytotoxic anti-cancer plant-derived drugs, digitalis and the pyrrolizidine alkaloids, etc. However, the adverse effects of phytotherapeutic agents are less frequent compared with synthetic drugs, but well-controlled clinical trials have now confirmed that such effects really exist. Several regulatory models for herbal medicines are currently available including prescription drugs, over-the-counter substances, traditional medicines and dietary supplements. Harmonization and improvement in the processes of regulation is needed, and the general tendency is to perpetuate the German Commission E experience, which combines scientific studies and traditional knowledge (monographs). Finally, the trend in the domestication, production and biotechnological studies and genetic improvement of medicinal plants, instead of the use of plants harvested in the wild, will offer great advantages, since it will be possible to obtain uniform and high quality raw materials which are fundamental to the efficacy and safety of herbal drugs.

참고문헌 (58)

0002-9459 American Journal of Pharmaceutical Education Farnsworth NR 148 46 1976 Higher plants - the sleeping giant of drug development
0012-6667 Drugs De Smet PAGM 54 801 1997 10.2165/00003495-199754060-00003 The role of plant-derived drugs and herbal medicines in healthcare

상세보기
0163-3864 Journal of Natural Products Cragg GM 60 52 1997 10.1021/np9604893 Natural products in drug discovery and development

상세보기
0163-3864 Journal of Natural Products Shu YZ 61 1053 1998 10.1021/np9800102 Recent natural products based drug development: A pharmaceutical industry perspective

상세보기
0899-5648 HerbalGram Akerele O 28 13 1993 Summary of WHO guidelines for the assessment of herbal medicines
0099-5355 Lancet Editorial 343 1513 1994 10.1016/S0140-6736(94)92931-9 Pharmaceuticals from plants: great potential, few funds

상세보기
0899-5648 HerbalGram Brevoort P 36 49 1995 The U.S. botanical market: An overview
0899-5648 HerbalGram Blumenthal M 45 68 1999 Harvard study estimates consumers spend $5.1 billion on herbal products?
0899-5648 HerbalGram Blumenthal M 45 67 1999 Herb industry sees mergers, acquisitions, and entry by pharmaceutical giants in 1998
1071-894X Pharmaceutical News Brevoort P 3 26 1996 Botanical (herbal) medicine in the United States

상세보기
0028-4793 New England Journal of Medicine Eisenberg DM 328 246 1993 10.1056/NEJM199301283280406 Unconventional medicine in the United States

상세보기
0267-0623 British Medical Journal Fisher P 309 107 1994 10.1136/bmj.309.6947.107 Complementary medicine in Europe

상세보기
0899-5648 HerbalGram Grünwald J 34 60 1995 The European phytomedicines market: figures, trends, analysis
Roberts JE New York 1998 Tyler's Herbs of Choice
Blumenthal M 1998 The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines
1 1993
1 1998
0092-8615 Drug Information Journal Keller K 30 933 1996 10.1177/009286159603000409 Herbal medicinal products in Germany and Europe: experiences with national and European assessment

상세보기
Schulz V 1996 Rational Phytotherapy: A Physicians' Guide to Herbal Medicine 3
0036-8075 Science Zeisel SH 285 1853 1999 10.1126/science.285.5435.1853 Regulation of "nutraceuticals"

상세보기
0378-8741 Journal of Ethnopharmacology Petrovick PR 66 51 1999 10.1016/S0378-8741(98)00149-4 New rules for phytopharmaceutical drug registration in Brazil

상세보기
Eskinazi D 1999 Botanical Medicine: Efficacy, Quality Assurance, and Regulation
0944-7113 Phytomedicine Brautigam MRH 5 425 1998 10.1016/S0944-7113(98)80038-X Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double blind placebo-controlled study

상세보기
0944-7113 Phytomedicine Kanowski S 4 3 1997 10.1016/S0944-7113(97)80021-9 Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia

상세보기
0099-5355 Lancet Kleijnen J 340 1136 1992 10.1016/0140-6736(92)93158-J Knipschild P Ginkgo biloba

상세보기
0003-990X Archives of General Psychiatry Ernst E 55 1026 1998 10.1001/archpsyc.55.11.1026 Complementary therapies for depression - An overview

상세보기
Arzneimittel-Forschung/Drug Research Harrer G 49 289 1999 Comparison of equivalent between the St: John's wort extract LoHyp-57 and fluoxetine
0940-5437 International Journal of Clinical Pharmacology and Therapeutics Josey ES 37 111 1999 St. John's wort: a new alternative for depression?
0031-7098 Pharmacopsychiatry Laakmann G 31 54 1998 10.1055/s-2007-979346 St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

상세보기
0267-0623 British Medical Journal Linde K 313 253 1996 10.1136/bmj.313.7052.253 St. John's wort for depression - an overview and meta-analysis of randomized clinical trials

상세보기
0022-3573 Journal of Pharmacy and Pharmacology Vitiello B 51 513 1999 10.1211/0022357991772781 Hypericum perforatum extracts as potential antidepressants

상세보기
Geriatric Psychiatry and Neurology Woelk H 7 S34 1994 10.1177/089198879400701s10 Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients

상세보기
0264-3774 British Journal of Clinical Pharmacology Armstrong NC 48 262 1999 10.1046/j.1365-2125.1999.00004.x The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials

상세보기
0944-7113 Phytomedicine Bauer R 2 193 1996 10.1016/S0944-7113(96)80041-9 Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies

상세보기
0098-7484 Journal of the American Medical Association Bell LP 261 3419 1989 10.1001/jama.1989.03420230073029 Cholesterol-lowering effects of psyllium hydrophilic mucilloid: Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia

상세보기
0098-7484 Journal of the American Medical Association Bensoussan A 280 1585 1998 10.1001/jama.280.18.1585 Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial

상세보기
0002-9165 American Journal of Clinical Nutrition Borchers AT 66 1303 1997 10.1093/ajcn/66.6.1303 Complementary medicine: A review of immunomodulatory effects of Chinese herbal medicines

상세보기
0099-5355 Lancet Diehm C 347 292 1996 10.1016/S0140-6736(96)90467-5 Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency

상세보기
0003-9926 Archives of Internal Medicine Fairfield KM 158 2257 1998 10.1001/archinte.158.20.2257 Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients

상세보기
Archives of Experimental Urology Grasso M 48 97 1995 Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia
Arzneimittel-Forschung/Drug Research Högel J 45 88 1995 Studies on the efficacy of unconventional therapies
0267-0623 British Medical Journal Johnson ES 291 569 1985 10.1136/bmj.291.6495.569 Efficacy of feverfew as prophylactic treatment of migraine

상세보기
0003-9926 Archives of Internal Medicine Masshour NH 158 2225 1998 10.1001/archinte.158.20.2225 Herbal medicine for the treatment of cardiovascular disease

상세보기
0305-1870 Clinical and Experimental Pharmacology and Physiology Morris J 22 414 1995 10.1111/j.1440-1681.1995.tb02032.x Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study

상세보기
0099-5355 Lancet Murphy JJ 2 189 1988 10.1016/S0140-6736(88)92289-1 Randomised double-blind placebo-controlled trial of feverfew in migraine prevention

상세보기
0333-1024 Cephalalgia Vogler BK 18 704 1998 10.1046/j.1468-2982.1998.1810704.x Feverfew as a preventive treatment for migraine: a systematic review

상세보기
0003-9926 Archives of Internal Medicine Warshafsky S 119 599 1993 Effect of garlic on total serum cholesterol: a meta-analysis
0098-7484 Journal of the American Medical Association Wilt TJ 280 1604 1998 10.1001/jama.280.18.1604 Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

상세보기
Térapie Bagheri H 53 77 1998 Fulminant hepatic failure after herbal medicine ingestion in children
Brinker F 1998 Herb Contraindications and Drug Interactions 2
0099-5355 Lancet Brown RG 340 673 1992 10.1016/0140-6736(92)92208-W Toxicity of Chinese herbal remedies

상세보기
Drug interactions. Adverse Drug Reactions and Toxicological Reviews D'Arcy PF 12 147 1993 Adverse reactions and interactions with herbal medicines: 2
0114-5916 Drug Safety De Smet PAGM 13 81 1995 10.2165/00002018-199513020-00003 Health risks of herbal remedies

상세보기
0899-5648 HerbalGram Farnsworth NR 29 36A 1993 Relative safety of herbal medicines
0025-729X Medical Journal of Australia Drew A 166 538 1997 10.5694/j.1326-5377.1997.tb123246.x Safety issues in herbal medicine: implications for the health professions

상세보기
0092-8615 Drug Information Journal Lazarowych NJ 32 497 1998 10.1177/009286159803200222 Use of fingerprinting and marker compounds for identification and standardization of botanical drugs: strategies for applying pharmaceutical HPLC analysis to herbal products

상세보기
0269-3879 Biomedical Chromatography Li F 12 78 1998 10.1002/(SICI)1099-0801(199803/04)12:2 3.0.CO;2-U Chromatography of medicinal plants and Chinese traditional medicines

상세보기
Foster S 1998 Tyler's Honest Herbal

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents) 원문보기

Abstract ▼ AI-Helper

참고문헌 (58)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트